Regulations.gov document
Attachment A FDA CDER Guidance for Industry Labeling Guidance for Butalbital…
Supporting & Related Material · FDA-1999-P-1857 · posted Jun 8, 2017
Key facts
| Document ID | FDA-1999-P-1857-0002 |
|---|---|
| Title | Attachment A FDA CDER Guidance for Industry Labeling Guidance for Butalbital, Acetaminophen and Caffeine Tablets USP or Butalbital, Acetaminophen and Caffeine Capsules USP September 1997 re: Citizen Petition from Mikart, Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-1999-P-1857 |
| Posted | Jun 8, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: